✦ LIBER ✦

ICL 670: effective oral iron chelation therapy

✍ Scribed by Poole, RM

Book ID: 120860555
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2003
Weight: 180 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200313760-00013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Iron-chelating therapy with the new oral

Iron-chelating therapy with the new oral agent ICL670 (Exjade®)

✍ M.D. Cappellini 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 125 KB

The oral iron chelator ICL670A (deferasi

The oral iron chelator ICL670A (deferasirox) does not protect myocytes against doxorubicin

✍ Brian B Hasinoff; Daywin Patel; Xing Wu 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 203 KB

Iron chelators ICL670 and 311 inhibit HI

Iron chelators ICL670 and 311 inhibit HIV-1 transcription

✍ Zufan Debebe; Tatyana Ammosova; Marina Jerebtsova; Joseph Kurantsin-Mills; Xiaom 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 622 KB

Deferasirox (ICL670; Exjade®), a Novel O

Deferasirox (ICL670; Exjade®), a Novel Orally Available Iron Chelator for Correction of Transfusion-Associated Iron Overload

✍ Tyagi, Preeta; Jain, Vinay K.; Crawford, Jeffrey 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 108 KB

Effects of ICL670 (deferasirox) on cardi

Effects of ICL670 (deferasirox) on cardiac iron concentrations

✍ George J Kontoghiorghes 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 37 KB

Redox Properties of the Iron Complexes o

Redox Properties of the Iron Complexes of Orally Active Iron Chelators CP20, CP502, CP509, and ICL670

✍ Martin Merkofer; Reinhard Kissner; Robert C. Hider; Willem H. Koppenol 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 German ⚖ 645 KB

## Abstract Redox cycling of iron is a critical aspect of iron toxicity. Reduction of a low‐molecular‐weight iron(III)‐complex followed by oxidation of the iron(II)‐complex by hydrogen peroxide may yield the reactive hydroxyl radical (OH^.^) or an oxoiron(IV) species (the __Fenton__ reaction). Comp